日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Gut microbiota and metabolite signatures predict severe immune-related adverse events in advanced hepatobiliary cancers

肠道菌群和代谢物特征可预测晚期肝胆癌患者发生严重免疫相关不良事件

Zhu, Chengpei; Zhang, Dongya; Wang, Yunchao; Zhang, Chenchen; Wang, Shanshan; Xue, Jingnan; Lan, Zhou; Xun, Ziyu; Zhang, Longhao; Chao, Jiashuo; Liang, Yajun; Xue, Wenbin; Pu, Zilun; Zhu, Taifeng; Ning, Cong; Sang, Xinting; Wang, Hanping; Jiang, Xianzhi; Yang, Xiaobo; Zhao, Haitao

Fully automated image updating for brain shift compensation after dural opening

硬脑膜切开术后脑移位补偿的全自动图像更新

Li, Chengpei; Evans, Linton T; Hong, Jennifer; Davis, Scott C; Roberts, David W; Paulsen, Keith D; Fan, Xiaoyao

Postoperative adjuvant TACE combined with lenvatinib and immune checkpoint inhibitors for hepatocellular carcinoma with high recurrence risks: a multicenter retrospective study

术后辅助性TACE联合乐伐替尼和免疫检查点抑制剂治疗高复发风险肝细胞癌:一项多中心回顾性研究

Huang, Ziyue; Zhu, Taifeng; Chen, Xiaokun; Piao, Mingjian; Tan, Yang; Li, Chengjie; Liu, Kai; Wang, Shanshan; Zhang, Lei; Du, Shunda; Zhu, Chengpei; Zhou, Kang; Yang, Xiaobo; Zeng, Daobing; Zhao, Haitao

Vitamin D alleviates type 2 diabetes by promoting autophagy and inhibiting inflammation via the NLRP3 inflammasome pathway.

维生素 D 通过促进自噬和抑制 NLRP3 炎症小体通路来缓解 2 型糖尿病。

Ren Qian, Zhang Ling, Ni Chengpei, Zhang Lewen, Hu Yudie, Xiao Min, Zhou Zhengyu

Local therapy overcomes primary resistance to target-immunotherapy combination in unresectable hepatocellular carcinoma

局部治疗克服了不可切除肝细胞癌对靶向免疫疗法联合治疗的原发性耐药性

Chen, Xiangqi; Piao, Mingjian; Zhou, Zixiang; Wang, Shanshan; Li, Shuofeng; Zhang, Nan; Sun, Boyu; Liu, Kai; Yang, Xu; Yang, Xiaobo; Shi, Xiaohua; Zhu, Chengpei; Zhao, Haitao

Immunotherapy change overcomes acquired resistance after chemo-immunotherapy in unresectable biliary tract cancer

免疫疗法的改变克服了不可切除胆道癌化疗-免疫疗法后产生的耐药性

Chen, Xiangqi; Zhou, Zixiang; Li, Shuofeng; Yu, Guanhua; Feng, Shi; Zhou, Ze; Sun, Boyu; Wang, Shanshan; Liu, Kai; Li, Chengjie; Piao, Mingjian; Wang, Mingming; Zhang, Yihong; Li, Hu; Zhu, Chengpei; Zhu, Zhenyu; Zhao, Haitao

Comparing spatial distributions of ALA-PpIX and indocyanine green in a whole pig brain glioma model using 3D fluorescence cryotomography

利用三维荧光冷冻断层扫描技术比较全猪脑胶质瘤模型中ALA-PpIX和吲哚菁绿的空间分布

Scorzo, Augustino V; Kwon, Caleb Y; Strawbridge, Rendall R; Duke, Ryan B; Chen, Kristen L; Li, Chengpei; Fan, Xiaoyao; Hoopes, P Jack; Roberts, David W; Paulsen, Keith D; Davis, Scott C

Gut microbiota and metabolites signatures of clinical response in anti-PD-1/PD-L1 based immunotherapy of biliary tract cancer

肠道菌群和代谢物特征与基于抗PD-1/PD-L1的胆道癌免疫疗法的临床反应相关

Zhu, Chengpei; Wang, Yunchao; Zhu, Ruijuan; Wang, Shanshan; Xue, Jingnan; Zhang, Dongya; Lan, Zhou; Zhang, Chenchen; Liang, Yajun; Zhang, Nan; Xun, Ziyu; Zhang, Longhao; Ning, Cong; Yang, Xu; Chao, Jiashuo; Long, Junyu; Yang, Xiaobo; Wang, Hanping; Sang, Xinting; Jiang, Xianzhi; Zhao, Haitao

Characterizations of multi-kingdom gut microbiota in immune checkpoint inhibitor-treated hepatocellular carcinoma

免疫检查点抑制剂治疗的肝细胞癌中多界肠道菌群的特征分析

Zhu, Chengpei; Zhang, Chenchen; Wang, Shanshan; Xun, Ziyu; Zhang, Dongya; Lan, Zhou; Zhang, Longhao; Chao, Jiashuo; Liang, Yajun; Pu, Zilun; Ning, Cong; Sang, Xinting; Yang, Xiaobo; Wang, Hanping; Jiang, Xianzhi; Zhao, Haitao

Conversion surgery intervention versus continued systemic therapy in patients with a response after PD-1/PD-L1 inhibitor-based combination therapy for initially unresectable biliary tract cancer: a retrospective cohort study

对于最初无法切除的胆道癌患者,在接受基于PD-1/PD-L1抑制剂的联合治疗后出现疗效,转化手术干预与继续全身治疗的比较:一项回顾性队列研究

Wang, Shanshan; Wang, Yunchao; Zhu, Chengpei; Liu, Kai; Chao, Jiashuo; Zhang, Nan; Piao, Mingjian; Yang, Xu; Zhang, Longhao; Long, Junyu; Xun, Ziyu; Zhang, Ting; Sang, Xinting; Yang, Xiaobo; Zhao, Haitao